(Press-News.org) In the fight against pollution, several regions in the U.S. have banned the use of plastic straws. Alternative materials exist, but most options are either too expensive to scale up, go limp in drinks or taste bad. But now, a team reporting in ACS Omega has developed a new type of bioplastic film from all-natural, degradable materials that can be rolled into a straw that doesn’t get soggy and is stronger than plastic.
As efforts to reduce plastic waste take hold, many researchers and companies have turned to plastic alternatives to fabricate straws that comply with new laws and regulations. But so far, most options either end up breaking down in a drink, like paper straws, or require extra steps and energy to manufacture, like metal or sugarcane straws. But some biopolymers, such as starch and lignin, are readily available as byproducts of other industrial processes and could serve as cheap bioplastic ingredients. Lignin’s natural strength could help overcome starch’s brittleness, especially when combined with a bio-based crosslinker, such as citric acid. So, Dickens Agumba, Duc Hoa Pham and Jaehwan Kim wanted to see if these materials could be combined into a plastic film that was tough, stable in water, yet would still break down when no longer needed.
To create the straws, the researchers blended lignin with either potato starch or polyvinyl alcohol — a more traditional bioplastic material — then added citric acid. They spread the slurry into a thin layer, rolled it into a cylinder and cured it at over 350 F. The bioplastic naturally self-adhered at the seam, but heat treatment set it and made it even stronger. In tests, the cylinders were stronger than those made of polypropylene plastic, yet still flexible. After two months outside, the plastic straws remained unchanged, while the team’s straws degraded significantly. The bioplastic film also offered UV protection, which could be useful for other applications, such as a coating for greenhouse windows. The researchers say that this material could not only reduce the amount of plastic waste in the environment, but also be used to create other, more sustainable bioplastic products from otherwise wasted materials.
The authors acknowledge funding from the National Research Foundation of Korea Creative Research Initiatives Program.
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter | Facebook | LinkedIn | Instagram
END
This starchy bioplastic could make soggy paper straws a thing of the past
2023-03-06
ELSE PRESS RELEASES FROM THIS DATE:
Octapharma USA research at AAAAI: cutaquig® study at higher infusion rates presented
2023-03-06
PARAMUS, N.J. (March 6, 2023) – Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting evaluating the efficacy and safety of cutaquig® (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) infusions at higher infusion parameters, potentially offering greater dosing flexibility for patients.
Subcutaneous immunoglobulin (SCIG) has been an accepted mode of infusion for over 30 years and, with its increased utilization, improvements in methodology now drive replacement therapy in patients with primary immune deficiency. To further explore dosing flexibility with potential reductions ...
Erratic sleep patterns linked to elevated blood pressure in teens with extra belly weight
2023-03-06
Research Highlights:
A new study found that the link between excess weight and higher blood pressure in adolescents was stronger among those who also had irregular sleep patterns.
Irregular sleep patterns contributed to elevated blood pressure in teens who had more visceral fat (excess weight in the belly/abdominal area).
The researchers suggest that school schedules and extracurricular responsibilities often clash with teens’ natural tendency to go to bed later and sleep later, which may lead to irregular timing of sleep and a cascade of consequences for heart health later in life.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, March 6, 2023
DALLAS, March ...
Temperature-stable TB vaccine safe, prompts immune response in NIH-supported study
2023-03-06
WHAT:
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. A non-temperature stable form of the candidate previously had been tested in several clinical trials. However, this was the first clinical trial of any subunit TB vaccine candidate in a temperature-stable (thermostable) form. Results are published in Nature Communications.
The ...
The Access to Advanced Health Institute reports encouraging results of first-in-human trial of its temperature-stable tuberculosis vaccine candidate
2023-03-06
The Access to Advanced Health Institute (AAHI) published results of a Phase 1 clinical trial demonstrating the safety and immune responses in a new vaccine against tuberculosis (TB), the world’s second deadliest infectious disease (NCT03722472). AAHI’s TB vaccine combines several proteins from Mycobacterium tuberculosis (Mtb), the bacterium that causes TB, into a fusion protein (“ID93”) with a proprietary immune-stimulating adjuvant (“GLA-SE”) in a freeze-dried formulation that can be stored at elevated temperatures ...
The next pandemic: Researchers develop tool to identify existing drugs to use in a future outbreak
2023-03-06
A global team of researchers has created an algorithmic tool that can identify existing drugs in order to combat future pandemics. The work, reported in the Cell Press journal Heliyon, offers the possibility of responding more quickly to public-health crises.
“There is no silver bullet to defeat the Covid pandemic as it takes us over a public-health roller-coaster of deaths and devastation,” explains Naomi Maria, an immunologist, a visiting scientist at New York University’s Courant Institute of Mathematical Sciences, and the paper’s lead author. “However, using this AI tool, coupled with in vitro data and other resources, we’ve ...
Cancer stage and receptor status indicate a breast cancer survivor’s risk of recurrence
2023-03-06
Study’s findings may lead to more personalized follow-up care for patients.
New research indicates that for patients with breast cancer, the cancer’s stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
For the study, Heather Neuman, MD, MS, of the University of Wisconsin, and her colleagues analyzed data on 8,007 patients with stage I–III breast cancer who participated in nine clinical trials from 1997–2013 ...
Bees follow linear landmarks to find their way home, just like the first pilots
2023-03-06
In the earliest days of human flight, before the invention of the first radio beacons and ground-based electronic systems, and modern GPS, pilots commonly navigated by following roads and railways – striking linear landscape elements at ground level that guide towards a destination of interest.
Enter the honeybee. A century of research has shown that honeybees are navigators par excellence. They can navigate by their sense of smell, the sun, the sky’s pattern of polarized light, vertical landmarks that stand out from the panorama, and possibly the Earth’s magnetic field. They are also clever learners, able to recognize associations between disparate ...
Community strategy reduced opioid overdose deaths in Pennsylvania counties
2023-03-06
PITTSBURGH, March 6, 2023 — The monthly opioid overdose death (ODD) rate fell by 30% in Pennsylvania counties that implemented a novel community-focused strategy developed by University of Pittsburgh researchers, according to a new study published today in the Journal of Studies on Alcohol and Drugs.
By analyzing counties that did or didn’t implement the Pennsylvania Opioid Overdose Reduction Technical Assistance Center (ORTAC) strategy over time, the researchers estimate that this cost-effective, community-led approach prevented 1,818 opioid-related deaths over two years.
“I ...
A mixture of trees purifies urban air best
2023-03-06
Conifers are generally better than broadleaved trees at purifying air from pollutants. But deciduous tree may be better at capturing particle-bound pollution. A new study led by the University of Gothenburg shows that the best trees for air purification depend on the type of pollutant involved.
Trees and other greenery in cities provide many benefits that are important for the well-being of residents. Leaves and needles on trees filter air pollutants and reduce exposure to hazardous substances in the air. But which trees purify the air most effectively? Researchers from the University ...
Potential treatment of autoimmune diseases revealed in new study
2023-03-06
Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune diseases like multiple sclerosis and rheumatoid arthritis. These diseases occur when the body’s immune response goes wiry. The immune system, which normally attacks pathogens and infections, instead attacks healthy cells and tissues. For the millions of people who suffer from autoimmune diseases worldwide, the result can be debilitating—rheumatoid arthritis causes excessive joint pain, while multiple sclerosis can disable one’s brain and spinal cord function.
“The key to the development of autoimmune ...